Our President and CEO, Alison Silva, will participate in a panel discussion entitled “Undervalued Emerging Biotech Companies Developing Breakthrough Therapies” at 12:00 p.m. on the Mackie Stage. The panel discussion involving biotech executives will be moderated by Mr. Eden Rahim of Next Edge Capital Corp.
At 3:10 p.m., also on the Mackie Stage, Ms. Silva will present a general overview of the Company and its initial focus on targeted therapies for the treatment of multiple cancers and other unmet medical needs.
The slide presentation will be available on the Company's website and on SlideShare at www.slideshare.net/CriticalOutcome following the live presentation.
If you are going to be at the conference, please be sure to visit us at Booth #512.